READ: ARW ON RNA
-
mRNA Delivery Is More Than Just The Vehicle: Think Outside — & Inside — The LNP
9/14/2022
This article is part three of a four-part series unpacking my biggest takeaways from the mRNA Therapeutics Summit, which took place in Boston on July 27 & 28, 2022.
-
To Advance An mRNA “Platform,” Forget Traditional Operational Structures
9/11/2022
This article is **part** **two** of a four-part series unpacking several best practices I gleaned from the mRNA Therapeutics Summit, which took place in Boston on July 27 & 28, 2022.
-
Don’t Get Uppity: Match mRNA Science To Your Capabilities — And Vice Versa
9/6/2022
This article is part one of a four-part series unpacking four of my biggest takeaways from the mRNA Therapeutics Summit, which took place in Boston on July 27 & 28, 2022.
-
What Violin Making Can Teach Us About mRNA Therapeutic Quality
8/8/2022
Managing the mRNA supply chain and working in mRNA process development may not look anything like the work a luthier does to hew an instrument from an ancient spruce tree. But violin craftmanship actually serves as a fantastic metaphor for the challenging work the mRNA therapeutics space is tackling in sourcing and qualifying raw materials and optimizing the critical IVT reaction.
-
What Playing RISK Can Teach Us About mRNA Manufacturing
7/11/2022
On the surface, it may seem as though there is little in common between playing a board game and manufacturing mRNA therapeutics. But as I see it, strategizing, playing, and winning at RISK is highly analogous to the challenges mRNA therapeutics companies will face as they strive to achieve a well-controlled and understood commercial scale manufacturing process.